PaulaKleinMD

Breast Cancer, Hematologic Oncology

Director, Breast Medical Oncology, Continuum Cancer Centers, NY; Beth Israel Medical Center

Overview of Dr. Klein

Dr. Paula Klein is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including The Mount Sinai Hospital, Mount Sinai West, Mount Sinai Morningside, and Mount Sinai Beth Israel. She received her medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice 31 years. Dr. Klein accepts several types of health insurance, listed below. She is one of 122 doctors at Mount Sinai Beth Israel and one of 87 doctors at Mount Sinai Morningside who specialize in Oncology. She has more than 20 publications and over 500 citings.

Office
325 W 15th St
New York, NY 10011
Book by Phone+1(408) 837-0431

Fax+1 212-604-6038

Education & Training

NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1996 - 1998
NYU Grossman School of MedicineResidency, Internal Medicine, 1986 - 1989
NYU Grossman School of MedicineInternship, Internal Medicine, 1986 - 1987
State University of New York Downstate Medical Center College of MedicineClass of 1986

Certifications & Licensure

NY State Medical License 1987 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Top Doctors: New York Metro Area Castle Connolly, 2014
New York Magazine: Top Doctors Castle Connolly, 2013-2014
CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013

Clinical Trials

Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer Start of enrollment: 2008 May 15
Active, not recruiting
Phase 3
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery Start of enrollment: 2009 May 15
Active, not recruiting
Phase 2
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer Start of enrollment: 2011 Jan 07
Completed
Phase 2
Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Start of enrollment: 2011 May 16
Completed
Not Applicable
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Active, not recruiting
Phase 3
Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI Start of enrollment: 2013 May 31
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Monitoring of estradiol levels in premenopausal women receiving adjuvant abemaciclib and ovarian function suppression.
Alaina J Kessler, Rima Patel, Emily Jane Gallagher, Tianxiang Sheng, Damodara Rao Mendu
Breast Cancer Research and Treatment. 2024-10-01
Diagnostic and Practical Challenges in Applying National Comprehensive Cancer Network Guidelines for Suspected Pathogenic TP53 Mosaicism.
Daniel I Nathan, Tehilla Brander, Julie Gold, Deborah Paul, Paula Klein
JCO Precision Oncology. 2024-07-01
1 citations
Results of a Phase Ib Study Investigating Durvalumab in Combination with Eribulin in Patients with HER2-Negative Metastatic Breast Cancer and Recurrent Ovarian Cancer.
Chrystal A Landry, Julia Blanter, Meng Ru, Julie Fasano, Paula Klein
Oncology. 2024-01-01

Press Mentions

Herceptin May Benefit Some Women with Early Breast CancerFebruary 6th, 2020
Long Haul for Breast Cancer Survivors: Disease Can Return After 20 YearsDecember 2nd, 2018
New Treatments Offer Hope for Advanced-Stage Breast Cancer PatientsAugust 28th, 2018
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Insurance Accepted

Aetna Choice POS II
BCBS Blue Card PPO
BCBS Illinois BlueChoice Select
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
First Health PPO
GHI PPO
Great West PPO
Health Alliance PPO
Healthfirst New York
HIP of New York - Select PPO
Humana ChoiceCare Network PPO
MagnaCare PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment